JPMORGAN CHASE & CO - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 147 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$41,000
-86.4%
8,978
-89.6%
0.00%
Q4 2018$302,000
+263.9%
86,352
+953.6%
0.00%
Q3 2018$83,000
+56.6%
8,196
+13.8%
0.00%
Q2 2018$53,000
-65.8%
7,200
-71.9%
0.00%
Q1 2018$155,000
+154.1%
25,624
+303.5%
0.00%
Q4 2017$61,000
-88.0%
6,351
-89.0%
0.00%
Q3 2017$508,000
-24.6%
57,554
+7.9%
0.00%
Q2 2017$674,000
+40.4%
53,323
+16.7%
0.00%
Q1 2017$480,000
+57.4%
45,694
+37.9%
0.00%
Q4 2016$305,00033,133
+87092.1%
0.00%
Q3 2016$0
-100.0%
38
-56.8%
0.00%
Q2 2016$1,000
-66.7%
88
-57.5%
0.00%
Q1 2016$3,000
-100.0%
207
-99.9%
0.00%
-100.0%
Q4 2015$6,522,000
-24.6%
227,819
-25.0%
0.00%0.0%
Q3 2015$8,650,000
+2.4%
303,917
+29.2%
0.00%0.0%
Q2 2015$8,447,000
+131.5%
235,146
+274.6%
0.00%
+100.0%
Q1 2015$3,649,000
+507.2%
62,779
+339.8%
0.00%
Q4 2014$601,000
-89.4%
14,274
-91.2%
0.00%
-100.0%
Q3 2013$5,653,000
+5.7%
161,548
-58.2%
0.00%0.0%
Q2 2013$5,349,000386,5290.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2015
NameSharesValueWeighting ↓
Orbimed Advisors 5,406,844$52,014,0000.66%
ETF MANAGERS GROUP, LLC 282,268$3,255,0000.24%
Mirae Asset Global Investments Co., Ltd. 1,470,996$14,151,0000.19%
Financial Gravity Companies, Inc. 4,467$42,0000.05%
GSA CAPITAL PARTNERS LLP 67,200$646,0000.04%
TCI Wealth Advisors, Inc. 7,766$75,0000.03%
Freedom Investment Management, Inc. 64,741$623,0000.03%
GAM Holding AG 83,940$808,0000.02%
SFMG, LLC 11,994$115,0000.02%
SHELL ASSET MANAGEMENT CO 95,127$915,0000.02%
View complete list of INSYS THERAPEUTICS INC NEW shareholders